TUDOR INVESTMENT CORP ET AL - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 127 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$221,811
-58.6%
10,365
+0.4%
0.00%
-75.0%
Q3 2022$536,000
-5.5%
10,327
-13.8%
0.01%
-20.0%
Q2 2022$567,000
-72.8%
11,986
-59.0%
0.02%
-69.4%
Q1 2022$2,082,000
+3.3%
29,254
+8.6%
0.05%
+44.1%
Q4 2021$2,015,000
+348.8%
26,946
+241.2%
0.03%
+385.7%
Q3 2021$449,000
-80.1%
7,897
-84.6%
0.01%
-83.7%
Q2 2021$2,261,000
+129.1%
51,376
+156.7%
0.04%
+115.0%
Q1 2021$987,000
-46.8%
20,011
-54.6%
0.02%
-61.5%
Q4 2020$1,856,000
+229.1%
44,086
+292.7%
0.05%
+85.7%
Q2 2020$564,000
+169.9%
11,227
+93.5%
0.03%
+366.7%
Q2 2017$209,000
-43.1%
5,802
-51.3%
0.01%
-45.5%
Q1 2017$367,000
-29.2%
11,902
-23.1%
0.01%
-15.4%
Q4 2016$518,000
+72.7%
15,470
+57.9%
0.01%
+30.0%
Q1 2015$300,000
-34.4%
9,800
+9.0%
0.01%
-37.5%
Q4 2014$457,000
-43.9%
8,987
-56.4%
0.02%
-44.8%
Q3 2014$815,00020,5960.03%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 511,186$43,686,00011.23%
GREAT POINT PARTNERS LLC 210,400$17,981,0002.80%
ARMISTICE CAPITAL, LLC 456,000$38,970,0002.34%
Matarin Capital Management, LLC 210,208$17,964,376,0001.16%
Sapphire Star Partners LP 8,168$698,0000.70%
Granahan Investment Management 103,320$8,830,0000.48%
FARALLON CAPITAL MANAGEMENT LLC 867,500$74,137,0000.44%
361 CAPITAL LLC 19,040$1,627,0000.35%
ALGERT GLOBAL LLC 17,922$1,532,0000.33%
AlphaMark Advisors, LLC 9,310$796,0000.32%
View complete list of ENANTA PHARMACEUTICALS INC shareholders